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Abstract
Objectives—To review research and evidence-based resources on skin cancer prevention and 
early detection and their importance for oncology nurses.
Data Sources—Journal articles, federal reports, cancer surveillance data, behavioral 
surveillance data.
Conclusion—Most cases of skin cancer are preventable. Survivors of many types of cancer are 
at increased risk of skin cancers.
Implications for Nursing Practice—Oncology nurses can play an important role in protecting 
their patients from future skin cancer morbidity and mortality.
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Most skin cancers are preventable, but incidence rates continue to rise, leading the US 
Surgeon General to deem skin cancer “a major public health problem.”1 In the United 
States, nearly 5 million people are treated for skin cancer each year, at a cost of $8.1 
billion.2 The three most common types of skin cancer, in order of incidence, are basal cell 
carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. Cutaneous BCC alone is 
thought to be more common than any other cancer and can be disfiguring, but is generally 
treatable.3 Cutaneous SCC is less common than BCC but, in rare cases, can lead to death.4 
Melanoma is less common than BCC and SCC, but is the skin cancer responsible for the 
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most deaths, and is also the most common skin cancer for which incidence and mortality 
data are systematically tracked in the US.1 According to national cancer incidence data, 
invasive melanoma is among the 10 most common invasive cancers for both men and 
women in the US.5 In 2012, the most recent year for which national data are available, 
67,753 people in the US were diagnosed with melanomas of the skin, and 9,251 people in 
the US died from the disease.5
Skin cancer incidence has been increasing. The number of persons treated for all skin 
cancers combined increased by 44% from the period 2002–2006 to 2007–2011.2 The 
incidence of melanoma has been increasing for several decades, with rates doubling between 
1982 and 2011.6,7 Mortality rates have remained relatively stable, although rates have risen 
slowly among males.6
Overall, skin cancers are most common among sun-sensitive populations, especially non-
Hispanic whites, who have approximately 25 times the incidence rate of melanoma 
compared with blacks and approximately six times the rate among Hispanics.1 Incidence 
rates are most common overall among males, although among those younger than age 50, 
rates are higher among females than males.1 Mortality rates are also higher among males 
and increase with age, similar to incidence rates. Although whites have the highest incidence 
and mortality rates, black and Hispanic populations are often diagnosed at later stages and 
have poorer survival outcomes.8
Skin cancer reporting poses challenges to our understanding of the disease. BCC and SCC 
are not captured in central cancer registries.9 Melanomas are required by law to be reported 
to central registries in all states. However, melanomas diagnosed at in situ or early invasive 
stages are often diagnosed and treated in outpatient settings and thus are prone to 
underreporting or delayed reporting.10
Risk Factors for Skin Cancer
Most skin cancers are caused by a combination of both non-modifiable (eg, genetic) and 
modifiable (eg, environmental) risk factors. The most common modifiable risk factor for 
skin cancer is exposure to ultraviolet radiation (UV). Table 1 provides estimates of relative 
risk for modifiable and non-modifiable skin cancer risk factors that have been reported in 
different epidemiologic studies.
Genetic Risk Factors
Genetic factors strongly influence the risk of skin cancer. The following individual 
characteristics increase the risk of skin cancer: having a naturally fair skin tone, light colored 
eyes, blonde or red hair, dysplastic nevi or many common moles, and skin that burns, 
freckles, reddens, or becomes painful after too much time in the sun.11 Having a previous 
diagnosis or family history of skin cancer, especially melanoma, also increases risk.12,13 
Less obvious genetic factors, such as gene variants or mutations, may also play a role in 
some melanomas among those without the traditional risk factors of fair skin and hair, and 
rarely, genetic syndromes such as Familial Atypical Mole Melanoma Syndrome and 
xeroderma pigmentosum are responsible for the development of melanoma.14–16
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Melanocytes, cells found in the basal layer of skin that give skin and eyes their color, are 
genetically programmed to produce a specific amount of melanin. The amount of melanin or 
degree of pigmentation is inversely correlated with sun sensitivity and skin cancer risk.17 
Melanin absorbs and scatters energy from UV light, protecting the epidermal cells from 
damage. The Fitzpatrick skin phototyping system provides a numerical classification based 
on the reaction of unexposed skin to UVA (tanning) and UVB (burning) radiation exposure. 
For example, Fitzpatrick Type I phototype is defined as very fair skin that burns easily and 
never tans; Type III is skin that burns and tans moderately; and Type VI skin never burns, 
tans profusely, and is naturally dark brown.18
In addition to skin tone, melanoma risk is associated with total nevi count. Melanomas often 
develop from nevi, and nevi indicate both genetic propensity to develop melanoma and UV 
exposure.19 Skin tone and nevi count are also somewhat associated; studies show that 
children with light skin, pales eyes, freckles, and a tendency to sunburn have a significantly 
higher nevi count.20 In addition, patterns of nevi differ by skin type, both by site on the body 
and by cell type.21
Melanoma incidence and mortality rates are highest among non-Hispanic whites because of 
their typically lighter skin tone. However, black and Hispanic patients tend to be diagnosed 
with melanoma at later stages and subsequently have poorer survival outcomes.8,22 
Differences in prognosis and survival rates may also be related to socioeconomic factors, 
which may include insurance or transportation disparities that delay diagnosis and 
treatment.23–25 Acral lentiginous melanoma (ALM) is a rare subtype of melanoma that is 
not thought to be UV-related because of its occurrence on the palms of the hands and soles 
of the feet. Blacks and non-Hispanic whites have similar rates of ALM, with slightly higher 
rates among Hispanics and lower among Asian/Pacific Islanders.26 However, the lower 
proportion of UV-related cancers among black and Hispanics means that a greater 
proportion of melanomas diagnosed among these groups are ALM type, which has poor 
prognosis; greater proportions of ALM may contribute, in part, to higher mortality rates 
among these groups as well.26
Modifiable Risk Factors: UV Exposure
Although genetic factors have perhaps the greatest influence on skin cancer risk, nearly all 
skin cancers are also related, at least in part, to UV exposure. UV exposure stimulates 
melanocytes to produce melanin, which can appear as tanned skin, and indicates damage to 
the skin, skin cells, and DNA; more intense exposures can result in sunburn, indicating cell 
death.27
Types of UV radiation—UV radiation is one part of the electromagnetic spectrum 
measuring in wavelength from 100 to 400 nanometers (nm). There are three subtypes of UV 
radiation: UVA, UVB, and UVC (Fig. 1). UVA rays have the longest wavelength, measuring 
from 315 to 400 nm. They are not absorbed by the ozone layer and penetrate deep into the 
skin, through the epidermal junction where the melanocytes reside in the basal layer, and are 
primarily responsible for premature skin aging. UVB rays are shorter, measuring from 280 
to 315 nm. Both UVA and UVB exposure can result in a tanned appearance.28 UVB creates 
Watson et al. Page 3
Semin Oncol Nurs. Author manuscript; available in PMC 2017 August 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
a tan by increasing melanin production that confers a minimal amount of photoprotection, 
equivalent to about an SPF of 3, and also indicates damage to the skin.29 UVA-induced tans 
are not thought to provide photoprotection.28,30 Most UVB radiation is absorbed by the 
ozone layer, but climate conditions can affect the amount.31 Overexposure to UVB radiation 
causes erythema, swelling, and pain, the characteristic signs of sunburn, which generally 
take several hours to develop.32 UVC rays are the shortest, measuring from 100 to 280 nm, 
and are absorbed by the ozone layer and the atmosphere.
Patterns of UV Exposure—UV exposure patterns have been associated with the 
development of different types of skin cancer and different anatomical distribution 
patterns.17 Chronic cumulative exposure, including occupational outdoor exposure, has been 
associated more commonly with BCC and SCC skin cancer.33 The distribution of BCC by 
anatomic site varies by histologic type, with nodular BCC most commonly appearing on the 
head and superficial BCC most commonly occurring on the trunk.34 In contrast to SCC skin 
cancers, melanoma is generally associated with intermittent exposure and a history of 
sunburn.17,35,36 Similar to BCC, though, melanoma may develop through multiple 
pathways, with one study finding that women with more nevi on the arm were at increased 
risk for developing a melanoma on the trunk; those with lower nevi counts tended to develop 
melanoma on the head and neck.37 Although outdoor workers are traditionally thought to be 
at increased risk of BCC and SCC, but not for melanoma, a pooled analysis combining 15 
studies showed that outdoor workers in UV-intense areas were at increased risk of 
melanoma.38
Variations in UV by Time and Place—UV radiation varies dramatically both daily and 
seasonally, as well as by latitude and altitude. The US Environmental Protection Agency has 
developed the UV Index, a tool to help individuals avoid overexposure to the sun. The UV 
Index Web site (http://www.epa.gov/sunsafety/uv-index-1) and mobile app provide daily and 
hourly UV intensity forecasts that are measured on a scale from 1 (low risk of danger from 
the sun’s UV rays for the average person) to 11 + (extreme risk of harm from unprotected 
sun exposure). UV intensity peaks at midday and on the summer solstice. For a list of 
average winter versus summer UV Indices for selected American cities, see Figure 2. UV 
intensity cannot be felt and must be measured. Because temperature does not always 
correlate with UV intensity, it is important to check the UV Index and heed the 
corresponding precautions.
Individuals living in locations closer to the equator or at higher altitudes have been 
considered to be at greatest risk for melanoma because of early studies linking latitude and 
altitude with the disease worldwide.39 However, differences in population demographics, 
sun protection behaviors, risk awareness, physician density, and melanoma case reporting 
also influence the observed association between area-level UV and melanoma incidence 
rates.39 One study found that melanoma risk did correlate with average annual UV exposure 
and residential history by county, although time spent outdoors was only associated with an 
increased risk of melanoma for those reporting this exposure at a young age.40 National 
cancer incidence data on melanoma has revealed a different risk pattern for American 
children. Wong et al41 found that children living in areas with low UV exposure had a 
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significantly greater incidence of melanoma compared with children living in areas with 
high UV exposure. The reasons for this finding have not been clearly elucidated, but sunburn 
in children living in low UV exposure areas may be a sign of intense, intermittent exposure 
(for example, during vacations).
Occupational UV Exposure—Occupational exposure to UV can increase risk of skin 
cancer among outdoor workers. Studies clearly demonstrate that outdoor workers are at 
increased risk of BCC and SCC.17,42 Some studies have not found an increased risk of 
melanoma among outdoor workers, or have even found a lower risk than indoor 
workers.42–44 However, studies examining outdoor workers in UV-intense areas have shown 
that these workers do appear to be at increased risk of melanomas of the head and neck.38,45 
Studies of melanoma and occupation are often limited by lack of information on other 
related factors, such as recreational exposure, protective gear used, and socioeconomic 
factors.
Risk of Skin Cancer among Cancer Survivors
Oncology patients and cancer survivors, whether skin cancers or other types of cancer, are at 
increased risk of a later diagnosis of BCC, SCC, or melanoma.46 Increased risk may be 
conferred by treatment (eg, radiation or BRAF inhibitors) or genetic factors such as BRCA 
mutations, which may increase risk of skin cancers.46–50 Additionally, immunosuppression 
related to the initial development of cancer or to treatment (such as an organ or stem cell 
transplant) can increase risk of a later skin cancer.51,52 Organ transplant recipients are at 
very high risk for developing UV-induced skin tumors, especially cutaneous SCCs.53,54 An 
increased risk of melanoma has been documented in patients with a history of prior skin 
cancer, Kaposi sarcoma, female breast cancer, ocular melanoma, prostate cancer, thyroid 
cancer, non-Hodgkin lymphoma, and chronic lymphocytic leukemia.46 Patients diagnosed 
with chronic lymphocytic leukemia and non-Hodgkin lymphoma are at increased risk for 
developing particularly aggressive skin cancers associated with poorer outcomes.55 
Childhood cancer survivors are also more likely to be diagnosed with skin cancers in 
adulthood.56,57
The risk of developing a second melanoma within 1 year after an initial diagnosis of 
melanoma is about 2%, with about 1% of patients developing a second melanoma each year 
for 2 to 15 years.58 Melanoma survivors are at increased risk of developing a second primary 
cancer at another site, especially skin cancers, but also cancers of the bone, soft tissue, colon 
and rectum, female breast, kidney, prostate, thyroid, non-Hodgkin lymphoma, and chronic 
lymphocytic leukemia.59,60 In one study, melanoma patients receiving a BRAF inhibitor for 
metastatic disease (vemurafenib) had a 26% chance of developing a SCC within a median 
timeframe of approximately 8 weeks; most of the SCCs were keratoacanthomatype, which 
generally have a good prognosis.61
Patients with different types of skin cancer vary regarding their prognosis, consequences, 
and experiences.62 In addition, the diagnosis of skin cancer may put patients at greater risk 
for subsequent skin cancers and other malignancies. Patients with BCC or SCC may be at 
increased risk of a later diagnosis of female breast cancer, lung cancer, and melanoma.63 
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Prior diagnosis with a cutaneous SCC appeared to be associated with poorer survival for 
later cancers.64 Additionally, a history of BCC or SCC imparts a very high risk of 
subsequent skin cancers; the risk of developing a second BCC within 3 years was 44%, and 
SCC was 18%; both representing a 10-fold increase in incidence compared with the general 
population.65
Behavioral Surveillance Data on UV Exposure
Because of the long lag time from UV exposure to development of skin cancer, self-reported 
behaviors (eg, use of sun protection and indoor tanning) and sunburn are often used as more 
immediate measures by which the success of skin cancer prevention efforts can be evaluated. 
Although any amount of UV exposure can affect skin cancer risk, entirely avoiding UV from 
the sun is neither realistic nor advisable. Spending time outdoors can provide opportunities 
for increased physical activity and improved mental health.66,67 Sun protection can help 
reduce risks of overexposure to UV when spending time outdoors.
Sun Protection and Sunburn
Although the scientific evidence clearly links excessive UV exposure to an increased risk for 
skin cancer, people in the US continue to report low rates of using sun protection, and high 
rates of indoor tanning device use and sunburn. Federal surveys such as the Youth Risk 
Behavior Survey and the National Health Interview Survey (NHIS) have periodically 
included questions about use of sun protection and indoor tanning in the past year. Data on 
sunburn among adults are available from NHIS, and from special studies for children and 
adolescents.
Sunburn
Sunburn is often used as a proxy for skin cancer risk because it takes into account individual 
sun sensitivity as well as UV exposure. Data from the NHIS demonstrated that sunburn was 
common among adults, with about 38% of adults (37% of women and 39% of men) in 2010 
reporting having experienced a sunburn in the past year. Sunburns were most common 
among non-Hispanic whites (47%) and adults under the age of 25 years (51%).68 Although 
federal surveys do not routinely ask children about sunburn, a longitudinal study from 
Massachusetts conducted in 2004 and 2007 found that more than 50% of children aged 10 to 
14 surveyed reported having been sunburned during the summer.69
Sun Protection
The NHIS asked respondents about the following methods of sun protection when outdoors 
for more than an hour on a sunny day: sunscreen with a sun protection factor (SPF) of 15 or 
higher, wearing protective clothing (wide-brimmed hats, long sleeves, long pants, or other 
clothing that reaches the ankles), and staying in the shade. NHIS data from 2010 (the most 
recent year for which data are available) indicated suboptimal skin cancer risk-related 
behaviors among US adults. For example, approximately 21% of men and 41% of women 
reported usually or always protecting themselves from the sun by using sunscreen with SPF 
15 or higher,68 and some of these individuals, particularly women, may have used sunscreen 
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to protect their faces but not other exposed skin.70 Approximately 46% of men and 34% of 
women usually or always protected themselves by wearing protective clothing, and about 
31% of men and 44% of women reported usually or always seeking shade to protect 
themselves from the sun.68 According to data from the 2013 Youth Risk Behavior Survey, 
only about 10% of US high school students used sunscreen with an SPF of 15 or higher 
always or most of the time when outside for more than 1 hour on a sunny day.71 There has 
also been a decrease in the prevalence of routine sunscreen use among high school students 
over time, dropping from 13.3% in 1999 to 10.1% in 2013.72
Indoor Tanning
Indoor tanning exposes users to intense UV to tan the skin for cosmetic purposes. Meta-
analyses have shown that indoor tanning increases risk of BCC, SCC, and melanoma.73–75 
The UV exposure from tanning devices is usually significantly more intense than the UV 
exposure one would receive when outdoors, especially the levels of UVA.76,77 For example, 
tanning devices have been found to expose users to an average of four to 13 times the 
amount of UVA present in noonday summer sun in Washington DC, with some devices 
exposing users to even higher amounts.78,79 The magnitude of the association between 
indoor tanning and melanoma varies from study to study, reflecting different populations and 
settings, although tanning more frequently and at younger ages is consistently associated 
with increased risk.1 A recent study conducted in Minnesota found that among women 
diagnosed with melanoma younger than age 30, 97% had participated in indoor tanning, 
reflecting a 6-fold increase in risk.80 Indoor tanning is most common among young non-
Hispanic white females ages 16 to 25, with more than 30% of this demographic group 
reporting indoor tanning in the past year, often frequently.81 In 2013, 13% of high school 
students reported that they had used an indoor tanning device in the past year, and use was 
even more common among older, female (20%) and non-Hispanic white (18%) students.71 
Highest use was observed among non-Hispanic white female students (31%) and 12th-grade 
female students (27%). Analyses of indoor tanning device use from 2009 to 2013 indicated 
significant decreases among females, non-Hispanic white females, and non-Hispanic black 
male students.82 Indoor tanning also remains common among certain adult groups. Although 
in 2013, only 4% of all US adults reported indoor tanning in the past year, indoor tanning 
was much more common among women under the age of 30 years (14%).83
Evidence-Based Strategies to Reduce Skin Cancer Risk
Many strategies have been proven effective in increasing use of sun protection and reducing 
sunburn and use of indoor tanning, thereby lowering the risk of skin cancer.
The Surgeon General’s Call to Action
In 2014, the Surgeon General released The Call to Action to Prevent Skin Cancer. This 
document described skin cancer as a major public health issue, and identified five strategic 
goals to reduce skin cancer in the US.1 The first goal aimed to increase opportunities for sun 
protection outdoors, for instance, by increasing the availability of shade in recreational, 
occupational, and educational settings. The second goal aimed to provide individuals with 
accurate information about UV exposure, through strategies such as developing targeted 
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messages about UV and skin cancer prevention, and ensuring that effective sun safety 
education is available in schools and workplaces. One strategy related to this goal that is 
relevant for nurses and other health care providers is the use of recommended preventive 
services, particularly the US Preventive Services Task Force (USPSTF) recommendations.84 
The third strategic goal of the Call to Action related to promoting policies that advance the 
national goal of preventing skin cancer; for instance, supporting inclusion of sun protection 
in school and workplace policies and education, strengthening policies enabling electronic 
reporting of reportable skin cancers, and supporting shade policies. The fourth strategic goal 
aimed to reduce harms from indoor tanning by communicating the harms of indoor tanning, 
ensuring that regulations and policies are enforced, and considering new ones. The fifth 
strategic goal aimed to strengthen research, surveillance, monitoring, and evaluation related 
to skin cancer prevention.
The Call to Action is a first step in promoting community awareness to prevent skin cancer. 
Using an existing health promotion model applied to melanoma prevention, some have 
suggested that patients need the knowledge, tools, and incentives to change behavior, and 
that community health awareness is also key.85 The Surgeon General’s goals to educate the 
community about UV exposure, the hazards of indoor tanning, and skin cancer prevention, 
as well as conducting research, are all well within the scope of practice for the oncology 
nurse.
One nursing organization has taken the lead on promoting the Call to Action. The 
Dermatology Nurses’ Association in their Position Statement recommends educating 
patients and the community about both primary and secondary prevention. In 2007, 
Dermatology Nurses’ Association endorsed the Children’s Melanoma Prevention 
Foundation’s “SunAWARE” acronym as their official prevention standard because it 
recommends avoiding unprotected exposure to UV radiation, never indoor tanning, proven 
sun protection practices, and routine skin self-examination.
The Community Guide
The Community Preventive Services Task Force (Task Force) is an independent, nonfederal, 
unpaid panel of public health and prevention experts that provides evidence-based findings 
and recommendations about community preventive services, programs, and policies to 
improve health.86 Its members represent a broad range of research, practice, and policy 
expertise in community preventive services, public health, health promotion, and disease 
prevention. Findings from the Task Force are published in “The Guide to Community 
Preventive Services” (The Community Guide).
Educational and Environmental/Policy Approaches—The Task Force recently 
conducted a review of the latest evidence regarding the effectiveness of interventions that 
combine educational and environmental/policy approaches to increase sun-safety 
behaviors.87 Educational interventions generally provide information about sun safety and 
the effects of UV radiation. Messages delivered in lectures or through small media can be 
reinforced by modeling or role playing (for children). Sun-protective environmental and 
policy changes include increasing the availability of sun-protective items (eg, sunscreen or 
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protective clothing), adding sun-protective features to the physical environment (eg, shade 
structures), and implementing sun-protection policies (eg, clothing guidelines, restrictions 
on outdoor activities during peak sunlight hours).
The Task Force found sufficient evidence to recommend such intervention approaches in 
several community settings, specifically childcare centers, primary and middle schools, 
outdoor occupational settings, and outdoor recreational and tourism settings. At the time of 
the review, the Task Force found insufficient evidence to issue a recommendation regarding 
the effectiveness of such intervention strategies in high schools and colleges.
Community-Wide Interventions—The Task Force also conducted a review of the 
evidence regarding the effectiveness of community-wide interventions.88 Such interventions 
seek to increase sun-safety behaviors within a community by targeting a large part of the 
population in a defined area. The Task Force found sufficient evidence to recommend multi-
component community-wide interventions to prevent skin cancer. Multi-component 
community-wide interventions use a combination of at least two or more strategies (ie, 
individual-directed strategies, mass media campaigns, and/or environmental/policy 
approaches) across at least two or more settings within a defined geographic area (eg, city, 
state province, country) in a coordinated effort to influence sun-safety behaviors. The Task 
Force also reviewed the scientific evidence regarding the effectiveness of mass media 
interventions for skin cancer prevention. Mass media interventions use communication 
channels such as print media (eg, newspapers, magazines), broadcast media (eg, radio, 
television), billboards, or the internet to disseminate information and/or behavioral guidance 
to wide audiences. The Task Force found insufficient evidence to determine the effectiveness 
of mass media interventions when implemented alone rather than in combination with other 
intervention strategies.
Provider-Focused Interventions
Since 2012, the USPSTF has recommended counseling children, adolescents, and young 
adults aged 10 to 24 years of age who have fair skin about minimizing their exposure to UV 
radiation to reduce the risk for skin cancer.84 The USPSTF found moderate-level evidence of 
a moderate net benefit of counseling among this population, with minimal harms. During the 
review, the USPSTF concluded that the current evidence regarding the benefits and harms of 
counseling adults older than age 24 years about minimizing exposure to UV is insufficient.84
In 2009 the USPSTF stated that the current evidence regarding skin cancer screening was 
insufficient to recommend screening for the general population. The USPSTF is currently 
(as of June 2016) re-reviewing the evidence regarding screening, and a draft 
recommendation released November 2015 stated that the latest evidence is still insufficient 
to recommend skin cancer screening for the average-risk population.89
Although screening is not recommended for the general population, many patients 
commonly seen by oncology nurses may be at increased risk of melanoma. Patients at high 
risk may include those having a previous history of cancer or other risk factors, such as 
having atypical nevi or many common nevi, having a family or personal history of skin 
cancer, occupational exposure, or intense exposure such as indoor tanning. Oncology nurses 
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can play an important role in raising awareness of skin cancer among these patients. Some of 
these high-risk patients may benefit from screening, skin self-exam, or increased awareness 
about skin cancer prevention and risk. In some cases, oncology nurses can assist patients by 
teaching them how to perform a total skin self-exam.90 Some patients with a history of 
melanoma, atypical nevi, or large number of common acquired nevi may benefit from total 
body photography, in which patients are usually provided a copy of their photographs for 
use in home surveillance.91,92 Electronic apps that capture and record nevi for subsequent 
comparison are also available.93
There are many valuable online resources available for nurses to complement their patient 
and community education. For more information on relevant resources including the UV 
Index, mole mapping, indoor tanning, skin cancer carcinogenesis, skin cancer diagnosis, and 
skin cancer self-assessment, please refer to Table 2.
Importance of Prevention for Cancer Survivors and Their Families
Despite being at increased risk of future skin cancers, research shows that survivors of 
childhood cancers, as well as adults previously diagnosed with BCC, SCC, or melanoma, 
often do not adequately protect their skin from UV exposure.94–96 Similarly, children of 
melanoma survivors do not appear to have different sun protection practices than those at 
average risk.97
For those at increased risk of skin cancer related to a previous cancer diagnosis or because of 
family history, sun protection is especially important. Several interventions have shown 
promise in reducing future risks of skin cancer among survivors. For example, an 
intervention study demonstrated that increased use of sun protection may reduce risks of 
skin cancer among organ transplant recipients.98 A Web-based intervention aimed at 
melanoma survivors demonstrated improved sun protection behaviors.99 An intervention to 
increase sun protection targeted specifically to children of melanoma survivors was shown to 
increase participants’ use of hats and reapplication of sunscreen, although a reduction in 
sunburns was not observed.100
While more research is needed to determine effective interventions to prevent future skin 
cancers among cancer survivors, oncology nurses can be important sources of information to 
educate their patients about the importance of sun protection during and after treatment. 
Currently, the core curriculum for oncology nurse training includes information on how to 
counsel patients to reduce their risk of skin cancer in the following ways: minimizing 
midday sun exposure, avoiding sunburn, avoiding the use of indoor tanning devices, using 
sun protection including sun protective clothing, regular use of sunscreen with SPF of 15 or 
higher, wearing eye protection, and avoiding sun exposure for infants <6 months of age.101 
These recommendations are consistent with the Centers for Disease Control and 
Prevention’s recommendations to reduce risk of skin cancers, available at: http://
www.cdc.gov/cancer/skin/.
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Role of Oncology Nurses
Oncology nurses play an important role in educating patients and their communities about 
skin cancer prevention. Nurses can work as advocates for their patients and communities, 
and can be involved in research regarding skin cancer prevention. Many oncology nurses 
orchestrate skin cancer screening events throughout the US in May for Skin Cancer 
Awareness Month. Others educate school children and promote the incorporation of shade in 
their communities. Nurses, working together with physicians, patients, and their 
communities, can play an important role in achieving the goals outlined in the Call to Action 
and preventing future cases of skin cancer.102
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FIGURE 1. 
Types of ultraviolet (UV) radiation and skin penetration. (Figure courtesy of the Children’s 
Melanoma Prevention Foundation, with permission).
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FIGURE 2. 
Average seasonal UV index value for selected US cities. (Data source: US Environmental 
Protection Agency. 2004. A Guide to the UV Index. Available at http://www.epa.gov/sites/
production/files/documents/uviguide.pdf).
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TABLE 2
Selected Internet Resources for Skin Cancer Prevention
Resources URL
General information
SunWise (National 
Environmental Education 
Foundation [NEEF])
https://www.neefusa.org/sunwise
Surgeon General’s Call to 
Action to Prevent Skin Cancer 
(Office of the Surgeon General)
http://www.surgeongeneral.gov/library/calls/prevent-skin-cancer/index.html
Information on Melanoma 
(National Cancer Institute 
[NCI])
http://www.cancer.gov/types/skin
Skin cancer (CDC) http://www.cdc.gov/cancer/skin/
Skin cancer prevention fact 
sheets (CDC)
http://www.cdc.gov/cancer/skin/basic_info/fact_sheets.htm
What You Need to Know About 
Skin Cancer (NCI) For Patients
http://www.cancer.gov/publications/patient-education/wyntk-skin-cancer/
Global Solar UV Index (EPA 
and the National Weather 
Service)
http://www.epa.gov/sunsafety
Skin Cancer (National Institutes 
of Health [NIH]) For Seniors
http://nihseniorhealth.gov/skincancer/skincancerdefined/01.html
Skin Care and Aging (NIH) https://www.nia.nih.gov/health/publication/skin-care-and-aging
Sunscreen (US Food and Drug 
Administration [FDA])
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/ucm239463.htm
Indoor tanning (FDA) http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm186687.htm
Ultraviolet radiation (World 
Health Organization)
http://www.who.int/uv/en/
SunSmart Resources (Cancer 
Council Victoria)
http://www.sunsmart.com.au/
Recommendations
Skin Cancer Screening 
Recommendations (US 
Preventive Services Task Force 
[USPSTF])
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/skin-cancer-screening
Counseling to Prevent Skin 
Cancer: Recommendations and 
Rationale (USPSTF)
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/skin-cancer-counseling
Guide to Community Preventive 
Services
http://www.thecommunityguide.org/cancer/index.html
Preventing Skin Cancer: 
Findings of the Task Force on 
Community Preventive Services 
on Reducing Exposure to 
Ultraviolet Light
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5215a1.htm
Partners
American Academy of 
Dermatology
https://www.aad.org/
American Academy of Family 
Physicians
http://www.aafp.org/home.html
American Academy of 
Pediatrics
https://www.aap.org/
American Cancer Society http://www.cancer.org/
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Resources URL
American Public Health 
Association
http://www.apha.org/
American School Health 
Association
http://www.ashaweb.org/
Children’s Melanoma 
Prevention Foundation
http://www.melanomaprevention.org/
Melanoma Research Foundation http://www.melanoma.org/
National Association of School 
Nurses
http://www.nasn.org/
National Cancer Institute http://www.cancer.gov/
National Council on Skin 
Cancer Prevention
http://www.skincancerprevention.org/
National Institute of 
Environmental Health Sciences
http://www.niehs.nih.gov/
Skin Cancer Foundation http://www.skincancer.org/
Society of Health and Physical 
Educators (SHAPE America)
http://www.shapeamerica.org/
Sun Safety Alliance http://www.sunsafetyalliance.org/
SunSafe Project, Norris Cotton 
Cancer Center, Dartmouth 
Medical School
http://www.cancer.dartmouth.edu/pf/sunsafe_programs.html
US Environmental Protection 
Agency
http://www.epa.gov/
Semin Oncol Nurs. Author manuscript; available in PMC 2017 August 01.
